Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shintaro Hosoe

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Bioscience, Biotechnology, and Biochemistry|September 25, 2004
First synthesis of (+/-)-robinlinHirosato Takikawa, Shintaro Hosoe, Keiko Ueda, et al.
Bioorganic & Medicinal Chemistry|August 2, 2022
Development of potent non-acylhydrazone inhibitors of intestinal sodium-dependent phosphate transport protein 2b (NaPi2b)Michihiro Maemoto, Yuuki Hirata, Shintaro Hosoe, et al.
Journal of Medicinal Chemistry|January 17, 2022
Discovery of Gut-Restricted Small-Molecule Inhibitors of Intestinal Sodium-Dependent Phosphate Transport Protein 2b (NaPi2b) for the Treatment of HyperphosphatemiaMichihiro Maemoto, Yuuki Hirata, Shintaro Hosoe, et al.
Bioorganic & Medicinal Chemistry|October 19, 2019
Development of a novel class of peroxisome proliferator-activated receptor (PPAR) gamma ligands as an anticancer agent with a unique binding mode based on a non-thiazolidinedione scaffoldKeisuke Yamamoto, Tomohiro Tamura, Rina Nakamura, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Bioscience, Biotechnology, and Biochemistry|September 25, 2004
First synthesis of (+/-)-robinlinHirosato Takikawa, Shintaro Hosoe, Keiko Ueda, et al.
Bioorganic & Medicinal Chemistry|August 2, 2022
Development of potent non-acylhydrazone inhibitors of intestinal sodium-dependent phosphate transport protein 2b (NaPi2b)Michihiro Maemoto, Yuuki Hirata, Shintaro Hosoe, et al.
Journal of Medicinal Chemistry|January 17, 2022
Discovery of Gut-Restricted Small-Molecule Inhibitors of Intestinal Sodium-Dependent Phosphate Transport Protein 2b (NaPi2b) for the Treatment of HyperphosphatemiaMichihiro Maemoto, Yuuki Hirata, Shintaro Hosoe, et al.
Bioorganic & Medicinal Chemistry|October 19, 2019
Development of a novel class of peroxisome proliferator-activated receptor (PPAR) gamma ligands as an anticancer agent with a unique binding mode based on a non-thiazolidinedione scaffoldKeisuke Yamamoto, Tomohiro Tamura, Rina Nakamura, et al.
Pageof 1